Methamphetamine and other ATS remain the leading substances for which people seek drug treatment in East and South-East Asia.The number of people receiving treatment for ATS use, mainly methamphetamine, has remained stable or declined in the majority of reporting countries – with the exception of…
The non-medical use of cannabis in Australia has remained broadly stable, while trends in New Zealand have levelled off after earlier growth.In Australia, cannabis use has remained relatively stable over the past 2 decades. However, between 2019 and 2022/23 cannabis use increased among women (…
The synthetic drugs market in the Near and Middle East remains dynamic, following disruptions in the supply of “captagon”.The Near and Middle East accounted for 77 per cent of global “captagon” seizures in 2020–2024, with production mainly in the Syrian Arab Republic and Lebanon and trafficking…
In Australia, multiple drug-related indicators show an increase in cocaine use and associated harm between 2010 and 2021, particularly among men. However, cocaine still plays a relatively small role in overall drug-related harm, with only 2.7 per cent of people in drug-related treatment reporting…
The subregion with the highest annual prevalence of use of "ecstasy" globally is Australia and New Zealand where "ecstasy" is mostly used in capsules and crystal form.In Australia, after a decline in the use and availability of "ecstasy" since the onset of the COVID-19 pandemic, use and…
Asia has increasingly become a transit and destination region for cocaine trafficking and use over the past decade, although the growth in indicators of availability and use is moderate.Cocaine seizures in Asia increased more than sixfold between 2015 and 2024. Additionally, the number of seizures…
As intensive methamphetamine use has increased in both Australia and New Zealand, associated health harms have also increased.In Australia, hospitalizations and the number of people in drug-related treatment related to methamphetamine use have increased over the long-term, although recent data…
Seizures of methamphetamine in Asia continue to rise, even as the reported number of dismantled methamphetamine laboratories declines.Methamphetamine seizures in Asia reached a record high in 2024, while the number of dismantled (and reported) methamphetamine laboratories declined to its lowest…
Seizures of methamphetamine continued rising in South-East Asia while declining in East Asia.The largest quantities of methamphetamine worldwide were seized in East and South-East Asia, accounting for 48 per cent of the world’s total in 2024.Seizures of methamphetamine have been declining over the…
Methamphetamine seizures now dominate overall seizures of amphetamine-type stimulants (ATS) in the Near and Middle East/South-West Asia.Until 2022, ATS seizures in the subregion were dominated by amphetamine – notably “captagon” – but methamphetamine seizures have continued to rise since while…
Seizures of methamphetamine have shown a clear upward trend in Oceania over the last decade.
Seizures of methamphetamine in Oceania reached a new record high in 2024, mainly driven by
rising seizures reported from Australia and New Zealand. At the same time, the…
In Australia, past-year methamphetamine use has declined since 2004, but among people who still used the drug, there are signs of increases in intensive use patterns.A similar trend is observed in New Zealand, where the police characterize the methamphetamine market as saturated. Intensive use of…
